{"name": "EKR Therapeutics",
 "permalink": "ekr-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/ekr-therapeutics",
 "homepage_url": "http://www.ekrtx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@EKRtx.com",
 "phone_number": "877.435.2524 ",
 "description": "",
 "created_at": "Sat Oct 15 02:14:42 UTC 2011",
 "updated_at": "Sat Oct 15 02:14:41 UTC 2011",
 "overview": "\u003Cp\u003EEKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       61],
      "assets/images/resized/0015/8226/158226v1-max-150x150.png"],
     [[204,
       84],
      "assets/images/resized/0015/8226/158226v1-max-250x250.png"],
     [[204,
       84],
      "assets/images/resized/0015/8226/158226v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "John",
      "last_name": "E. Bailye",
      "permalink": "john-e-bailye",
      "image": null}},
   {"is_past": false,
    "title": "COO, CFO",
    "person":
     {"first_name": "Bill",
      "last_name": "McKee",
      "permalink": "bill-mckee",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 150000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020120515e85ftbj44\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120515e85ftbj44%26from%3dalert%26pid%3d32",
   "source_description": "Cornerstone Thera to Acquire EKR Thera For $150M Cash, Milestones ",
   "acquired_year": 2012,
   "acquired_month": 5,
   "acquired_day": 15,
   "acquiring_company":
    {"name": "Cornerstone Therapeutics",
     "permalink": "cornerstone-therapeutics",
     "image":
      {"available_sizes":
        [[[150,
           35],
          "assets/images/resized/0016/8878/168878v1-max-150x150.png"],
         [[250,
           59],
          "assets/images/resized/0016/8878/168878v1-max-250x250.png"],
         [[264,
           63],
          "assets/images/resized/0016/8878/168878v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1545 US Highway 206",
    "address2": "Third Floor",
    "zip_code": "07921 ",
    "city": "Bedminster",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}